BLB&B Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-337
| Closed | -$225K | – | 258 |
|
|
2021
Q4 | $225K | Sell |
337
-961
| -74% | -$600K | 0.01% | 242 |
|
|
2021
Q3 | $742K | Buy |
1,298
+116
| +10% | +$63.7K | 0.05% | 151 |
|
|
2021
Q2 | $596K | Sell |
1,182
-2
| -0.2% | -$944 | 0.04% | 155 |
|
|
2021
Q1 | $540K | Buy |
1,184
+2
| +0.2% | +$955 | 0.04% | 157 |
|
|
2020
Q4 | $551K | Sell |
1,182
-58
| -5% | -$27.2K | 0.04% | 163 |
|
|
2020
Q3 | $547K | Hold |
1,240
| – | – | 0.06% | 154 |
|
|
2020
Q2 | $449K | Buy |
1,240
+7
| +0.6% | +$2.35K | 0.05% | 170 |
|
|
2020
Q1 | $350K | Sell |
1,233
-5
| -0.4% | -$1.58K | 0.05% | 184 |
|
|
2019
Q4 | $402K | Buy |
1,238
+2
| +0.2% | +$606 | 0.04% | 197 |
|
|
2019
Q3 | $360K | Hold |
1,236
| – | – | 0.04% | 205 |
|
|
2019
Q2 | $363K | Sell |
1,236
-16
| -1% | -$4.41K | 0.04% | 203 |
|
|
2019
Q1 | $343K | Hold |
1,252
| – | – | 0.04% | 210 |
|
|
2018
Q4 | $280K | Buy |
1,252
+51
| +4% | +$12K | 0.04% | 222 |
|
|
2018
Q3 | $293K | Sell |
1,201
-300
| -20% | -$69K | 0.04% | 244 |
|
|
2018
Q2 | $311K | Sell |
1,501
-200
| -12% | -$42.5K | 0.04% | 232 |
|
|
2018
Q1 | $351K | Sell |
1,701
-90
| -5% | -$18.9K | 0.05% | 220 |
|
|
2017
Q4 | $340K | Hold |
1,791
| – | – | 0.05% | 224 |
|
|
2017
Q3 | $339K | Buy |
1,791
+25
| +1% | +$4.53K | 0.05% | 210 |
|
|
2017
Q2 | $308K | Hold |
1,766
| – | – | 0.05% | 221 |
|
|
2017
Q1 | $271K | Hold |
1,766
| – | – | 0.05% | 236 |
|
|
2016
Q4 | $249K | Sell |
1,766
-25
| -1% | -$3.69K | 0.04% | 242 |
|
|
2016
Q3 | $285K | Buy |
1,791
+200
| +13% | +$30.8K | 0.05% | 224 |
|
|
2016
Q2 | $235K | Hold |
1,591
| – | – | 0.04% | 245 |
|
|
2016
Q1 | $225K | Buy |
+1,591
| New | +$213K | 0.05% | 243 |
|
Other funds holding TMO
